Kinin receptors: Functional aspects

International Immunopharmacology

Volumn 2, Issue 13-14, 2002, Pages 1729-1739

  Marceau, François ^a   Sabourin, Thierry ^a   Houle, Steeve ^a   Fortin, Jean Philippe ^a   Petitclerc, Eric ^a   Molinaro, Giuseppe ^b   Adam, Albert ^b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

B1 receptor for kinins; B2 receptor for kinins; Green fluorescent protein; NF B; Polymorphonuclear leukocytes; Receptor down regulation; Receptor translocation and endocytosis; Trypsin

Indexed keywords

BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; CYTOKINE; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KALLIDIN[1-9]; KININ; PROTEINASE; RECEPTOR PROTEIN; RECEPTOR SUBTYPE; TRYPSIN; BRADYKININ RECEPTOR; PHOTOPROTEIN;

AGONIST; AORTA; ARTICLE; CAVEOLA; CELL SURFACE; CELLULAR DISTRIBUTION; ENDOCYTOSIS; HUMAN; INTERNALIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; RABBIT; RECEPTOR DOWN REGULATION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; VASCULAR TISSUE; ANIMAL; CELL LINE; CYTOLOGY; DOWN REGULATION; DRUG POTENTIATION; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; REVIEW; VASCULAR ENDOTHELIUM;

ANIMALS; CAVEOLAE; CELL LINE; DOWN-REGULATION; ENDOCYTOSIS; ENDOTHELIUM, VASCULAR; GREEN FLUORESCENT PROTEINS; LUMINESCENT PROTEINS; PHOSPHORYLATION; RABBITS; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2; RECEPTORS, BRADYKININ; RECOMBINANT FUSION PROTEINS;

EID: 0036891711     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(02)00189-3     Document Type: Review

References (42)

1. 1 receptors for kinins. Pharmacol. Rev. 50:1998;357-386.
2. Milligan G. Exploring the dynamics of regulation of G protein-coupled receptors using green fluorescent protein. Br. J. Pharmacol. 128:1999;501-510.
3. 2 receptor. Hypertension. 35:2000;1319-1325.
4. 2 receptor endocytosis and recycling assessed using green fluorescent protein conjugates. J. Pharmacol. Exp. Ther. 297:2001;19-26.
5. 1 receptor to caveolae-related rafts. Mol. Pharmacol. 61:2002;546-553.
6. Abe Y., Nakayama K., Yamanaka A., Sakurai T., Goto K. Subtype-specific trafficking of endothelin receptors. J. Biol. Chem. 275:2000;8664-8671.
7. Jagels M.A., Travis J., Potempa J., Pike R., Hugli T.E. Proteolytic inactivation of the leukocyte C5a receptor by proteinases derived from Porphyromonas gingivalis. Infect. Immun. 64:1996;1984-1991.
8. i in caveolae in DDT1 MF-2 smooth muscle cells. J. Biol. Chem. 272:1997;17858-17866.
9. 2 receptor in caveolae. J. Cell Sci. 111:1998;917-928.
10. 1 MF-2 smooth muscle cells process internalized bradykinin via multiple degradation pathways. J. Biol. Chem. 267:1992;303-309.
11. Blaukat A., Abd Alla S., Lohse M.J., Müller-Esterl W. Ligand-induced phosphorylation/dephosphorylation of the endogenous bradykinin B2 receptor from human fibroblasts. J. Biol. Chem. 271:1996;32366-32374.
12. 2 receptor requires phosphorylation of three serine and two threonine residues at its carboxyl tail. J. Biol. Chem. 274:1999;12738-12747.
13. 2 receptors. Eur. J. Pharmacol. 294:1995;173-182.
14. Bartus R.T., Elliott P.J., Dean R.L., Hayward N.J., Nagle T.L., Huff M.R.et al. Controlled modulation of BBB permeability using the bradykinin agonist, RMP-7. Exp. Neurol. 142:1996;14-28.
15. Sabourin T., Guay K., Houle S., Bouthillier J., Bachvarov D.R., Adam A.et al. Absence of ligand-induced regulation of kinin receptor expression in the rabbit. Br. J. Pharmacol. 133:2001;1154-1162.
16. 2 receptors in acute renal transplant rejection. Immunopharmacology. 33:1996;157-160.
17. 9-bradykinin on ion transport across normal and inflamed rat colonic mucosa. Gastroenterology. 90:1986;1481. [abstract].
18. Sung C.P., Arleth A.J., Shikano K., Zabko-Potapovich B., Berkowitz B.A. Effect of trypsinization in cell culture on bradykinin receptors in vascular endothelial cells. Biochem. Pharmacol. 38:1989;696-699.
19. 2 receptor is activated by kallikrein and other serine proteases. Mol. Pharmacol. 58:2000;826-836.
20. 9]bradykinin, a B2 receptor selective agonist which is not broken down by either kininase I or kininase II. Eur. J. Pharmacol. 155:1988;193-195.
21. 2 receptor. J. Pharmacol. Exp. Ther. 275:1995;1623-1630.
22. Corish P., Tyler-Smith C. Attenuation of green fluorescent protein half-life in mammalian cells. Protein Eng. 12:2000;1035-1040.
23. Böyum A. Isolation of leukocytes from human blood. Scand. J. Clin. Lab. Invest. 21(suppl. 9):1968;9-29.
24. Finch A.M., Vogen S.M., Sherman S.A., Kirnarsky L., Taylor S.M., Sanderson S.D. Biologically active conformer of the effector region of human C5a and modulatory effects of N-terminal receptor binding determinants on activity. J. Med. Chem. 40:1997;877-884.
25. Bachvarov D.R., Houle S., Bachvarova M., Bouthillier J., St-Pierre S.A., Fukuoka Y.et al. Cloning and preliminary pharmacological characterization of the anaphylatoxin C5a receptor in the rabbit. Br. J. Pharmacol. 128:1999;321-326.
26. Chenoweth D.E., Hugli T.E. Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes. Proc. Natl. Acad. Sci. U. S. A. 75:1978;3943-3947.
27. Chapman H.A., Riese R.J., Shi G.P. Emerging roles for cysteine proteases in human biology. Annu. Rev. Physiol. 59:1997;63-88.
28. Faussner A., Proud D., Towns M., Bathon J.M. Influence of the cytosolic carboxyl termini of human B1 and B2 kinin receptors on receptor sequestration, ligand internalization, and signal transduction. J. Biol. Chem. 273:1998;2617-2623.
29. 1 receptor gene expression through absence of internalization and resensitization. J. Cell Biochem. 78:2000;351-362.
30. Blaukat A., Herzer K., Schroeder C., Bachmann M., Nash N., Müller-Esterl W. Overexpression and functional characterization of kinin receptors reveal subtype-specific phosphorylation. Biochemistry. 38:1999;1300-1309.
31. Blais C., Marceau F., Rouleau J.L., Adam A. The kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins. Peptides. 21:2000;1903-1940.
32. Ostrom R.S. New determinants of receptor-effector coupling: trafficking and compartmentation in membrane microdomains. Mol. Pharmacol. 61:2002;473-476.
33. Regoli D., Barabé J., Park W.K. Receptors for bradykinin in rabbit aortae. Can. J. Physiol. Pharmacol. 55:1977;855-867.
34. 1 receptor. Br. J. Pharmacol. 131:2000;885-892.
35. 1 in human lung fibroblasts. Mol. Pharmacol. 56:1999;325-333.
36. 1 receptors and development of a cellular model for the investigation of these receptors. Br. J. Pharmacol. 109:1993;1254-1262.
37. 1 receptors for kinins. Immunopharmacology. 29:1995;141-147.
38. Levesque L., Larrivée J.F., Bachvarov D.R., Rioux F., Drapeau G., Marceau F. Regulation of kinin-induced contraction and DNA synthesis by inflammatory cytokines in the smooth muscle of the rabbit aorta. Br. J. Pharmacol. 116:1995;1673-1679.
39. Sabourin T., Morissette G., Bouthillier J., Levesque L., Marceau F. Expression of kinin B1 receptor in fresh or cultured rabbit aortic smooth muscle: role of NF-κB. Am. J. Physiol. Heart Circ. Physiol. 283:2002;227-237.
40. 1 receptor gene in inflammation. J. Biol. Chem. 273:1998;2784-2791.
41. 1-receptor in cultured human lung fibroblasts. J. Clin. Invest. 101:1998;2080-2091.
42. 1 receptor expression by endogenous glucocorticoids hormones in rats. Br. J. Pharmacol. 132:2001;567-577.